This toolkit provides detailed steps for using prescription drug claims data to analyze patients' opioid levels and identify certain patients who are at risk of opioid misuse or overdose. It is based on the methodology that OIG has developed in our extensive work on opioids. This new OIG product provides highly technical information to support our public and private sector partners, such as Medicare Part D plan sponsors, private health plans, and State Medicaid Fraud Control Units. It is intended to assist our partners with analyzing their own prescription drug claims data to help combat the opioid crisis.
Wednesday, June 27, 2018
Agency Reviewed / Investigated:
Submitting OIG-Specific Report Number:
Component, if applicable:
Centers for Medicare & Medicaid Services
Type of Report:
Inspection / Evaluation